Trading patterns indicate elevance stock price is consolidating near $495, with volatility measures dropping, often a precursor to sharp moves. Institutional accumulation continues to show up in daily block trades. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. On Aug. 15, Wells Fargo analyst Stephen Baxter reiterated an “Overweight” rating on Elevance Health but lowered the price target from $400 to $330, reflecting a more cautious outlook despite maintaining a positive stance on the stock. The elevance stock price has been outperforming the S&P Health Care index year-to-date, currently at $
